首页 › 基金 › PRELUDE CAPITAL MANAGEMENT, LLC › TECH
PRELUDE CAPITAL MANAGEMENT, LLC 对 TECH 的持仓历史
BIO-TECHNE CORP · 医疗保健
PRELUDE CAPITAL MANAGEMENT, LLC 在 Q2 2026 的 13F 申报中披露持有 TECH(BIO-TECHNE CORP)91,696 股,市值约 US$6.5M,约占其申报组合的 0.52%,在其申报持仓中市值排名第 28 位。 PRELUDE CAPITAL MANAGEMENT, LLC 最近 12 个申报季度中有 7 个季度披露了 TECH 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
PRELUDE CAPITAL MANAGEMENT, LLC 对 TECH 的持仓演变
PRELUDE CAPITAL MANAGEMENT, LLC 于 Q3 2023 首次披露 TECH 持仓:6,791 股(约 US$462K)。 该持仓在 Q2 2026 达到峰值 91,696 股,市值约 US$6.5M。 在 7 次申报中,PRELUDE CAPITAL MANAGEMENT, LLC 2 次增持、2 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 91,696 股、市值约 US$6.5M。 持仓曾出现大幅变动:Q4 2023 增持约 68% (随后一个季度股价下跌 9%)、Q1 2024 增持约 127% (随后一个季度股价上涨 2%)、Q3 2024 减持约 82% (随后一个季度股价下跌 10%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 6.79K | $462.26K | 新进 |
| Q4 2023 | 11.39K | $879.16K | 增持 |
| Q1 2024 | 25.88K | $1.82M | 增持 |
| Q2 2024 | 19.32K | $1.38M | 减持 |
| Q3 2024 | 3.51K | $280.71K | 减持 |
| Q2 2025 | 9.53K | $490.32K | 新进 |
| Q2 2026 | 91.70K | $6.48M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TECH 与 13F 数据
TECH(BIO-TECHNE CORP)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 TECH,申报仓位最大的包括:HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb(红杉基金) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TECH 的基金
- HBK INVESTMENTS L P 6.83M 股 · $482.19M · Q2 2026
- Ruane Cunniff & Goldfarb(红杉基金) 3.35M 股 · $236.60M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 3.16M 股 · $223.52M · Q2 2026
- MAIRS & POWER INC 2.70M 股 · $190.80M · Q2 2026
- WHITEBOX ADVISORS LLC 2.10M 股 · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M 股 · $126.56M · Q4 2025
更多关于 PRELUDE CAPITAL MANAGEMENT, LLC
常见问题
How long has PRELUDE CAPITAL MANAGEMENT, LLC held TECH?
PRELUDE CAPITAL MANAGEMENT, LLC has disclosed TECH holdings in 7 of the last 12 reported quarters, going back to Q3 2023.
What is PRELUDE CAPITAL MANAGEMENT, LLC's current position in TECH?
As of Q2 2026, PRELUDE CAPITAL MANAGEMENT, LLC holds 91.70K shares of TECH (BIO-TECHNE CORP), valued at $6.48M, representing 0.52% of its reported portfolio and ranking #28.
Has PRELUDE CAPITAL MANAGEMENT, LLC been buying or selling TECH?
In the latest 13F filing (Q2 2026), PRELUDE CAPITAL MANAGEMENT, LLC newly opened its position in TECH. The position peaked in Q2 2026 at 91.70K shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb(红杉基金), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.